Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Trends in neuroendocrine tumor-related mortality, 1999–2020: A CDC WONDER database analysis.

View through CrossRef
e18155 Background: Every year, around 6 individuals per 100,000 population in the United States (US) are affected by neuroendocrine tumors (NETs). Although NETs are rare, their incident rates are continuously increasing. This study aims to analyze NET-related mortality trends in the US among the population aged 55 and above and to evaluate shifting trends among different demographics and geographical sub-divisions. Methods: The publicly available database of CDC WONDER was used for retrieving death certificates for patients above 55 years in United States from 1999 to 2020 using ICD-10: C73-C75 (Malignant neoplasms of thyroid and other endocrine glands). Demographic indicators of gender, race, urbanization, census region, and state location were used for calculation age adjusted mortality rates (AAMR) per 100,000 at significant level of p<0.05. Results: A total of 52,465 NET-related deaths occurred in adults aged 55 and above from 1999 to 2020. The overall age-adjusted mortality rate (AAMR) increased from 3.1 in 1999 to 3.5 in 2020. The overall AAMR significantly increased in males and females throughout the study period. In contrast, males continuously had higher AAMR as compared to females (Overall AAMR: Male: 3.3, Female: 3.2). Among races, the overall AAMR was highest in Non-Hispanic (NH) Asians (3.6) followed by Hispanics (3.5), NH whites (3.3) and NH Blacks (3.1). While evaluating the data geographically, non-metropolitan areas had higher overall AAMR (3.4) than metropolitan areas (3.3). Among regions, the West had the highest total AAMR (3.6), followed by the Midwest (3.4), Northeast (3.3) and South (3.1). States with AAMRs included in the top 90th percentile are South Dakota and North Dakota (3.9), California (3.8), Oregon and New Mexico (3.7). Conclusions: There is an increase in overall age-adjusted mortality trends in neuroendocrine tumours in almost all of the demographics and geographic subgroups. This increasing trend stresses the urgent need for targeted interventions and resource allocation to address these disparities and achieve positive results.
Title: Trends in neuroendocrine tumor-related mortality, 1999–2020: A CDC WONDER database analysis.
Description:
e18155 Background: Every year, around 6 individuals per 100,000 population in the United States (US) are affected by neuroendocrine tumors (NETs).
Although NETs are rare, their incident rates are continuously increasing.
This study aims to analyze NET-related mortality trends in the US among the population aged 55 and above and to evaluate shifting trends among different demographics and geographical sub-divisions.
Methods: The publicly available database of CDC WONDER was used for retrieving death certificates for patients above 55 years in United States from 1999 to 2020 using ICD-10: C73-C75 (Malignant neoplasms of thyroid and other endocrine glands).
Demographic indicators of gender, race, urbanization, census region, and state location were used for calculation age adjusted mortality rates (AAMR) per 100,000 at significant level of p<0.
05.
Results: A total of 52,465 NET-related deaths occurred in adults aged 55 and above from 1999 to 2020.
The overall age-adjusted mortality rate (AAMR) increased from 3.
1 in 1999 to 3.
5 in 2020.
The overall AAMR significantly increased in males and females throughout the study period.
In contrast, males continuously had higher AAMR as compared to females (Overall AAMR: Male: 3.
3, Female: 3.
2).
Among races, the overall AAMR was highest in Non-Hispanic (NH) Asians (3.
6) followed by Hispanics (3.
5), NH whites (3.
3) and NH Blacks (3.
1).
While evaluating the data geographically, non-metropolitan areas had higher overall AAMR (3.
4) than metropolitan areas (3.
3).
Among regions, the West had the highest total AAMR (3.
6), followed by the Midwest (3.
4), Northeast (3.
3) and South (3.
1).
States with AAMRs included in the top 90th percentile are South Dakota and North Dakota (3.
9), California (3.
8), Oregon and New Mexico (3.
7).
Conclusions: There is an increase in overall age-adjusted mortality trends in neuroendocrine tumours in almost all of the demographics and geographic subgroups.
This increasing trend stresses the urgent need for targeted interventions and resource allocation to address these disparities and achieve positive results.

Related Results

Theoretical study of laser-cooled SH<sup>–</sup> anion
Theoretical study of laser-cooled SH<sup>–</sup> anion
The potential energy curves, dipole moments, and transition dipole moments for the <inline-formula><tex-math id="M13">\begin{document}${{\rm{X}}^1}{\Sigma ^ + }$\end{do...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract Introduction Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
Rising Mortality Rates of Cholecystitis in the United States (1999-2020): A CDC WONDER Analysis
Rising Mortality Rates of Cholecystitis in the United States (1999-2020): A CDC WONDER Analysis
IntroductionCholecystitis, typically caused by gallstone obstruction, presents with fever and right upper quadrant pain and may lead to severe complications like sepsis or death if...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract Introduction Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation
Abstract 1801: FOXA1, a novel regulator of neuroendocrine differentiation
Abstract Neuroendocrine prostate cancer (NEPC) is a subtype of prostate cancer that is highly aggressive and exhibits a neuroendocrine phenotype, being distinct from...
Localization of immunoreactive HIF‐1α and HIF‐2α in neuroendocrine cells of both benign and malignant prostate glands
Localization of immunoreactive HIF‐1α and HIF‐2α in neuroendocrine cells of both benign and malignant prostate glands
AbstractBACKGROUNDHypoxia induces increased tumor growth by promoting angiogenic and glycolytic pathways. Tumors expressing hypoxia‐inducible factor‐1α (HIF‐1α), an important trans...

Back to Top